Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

Cannabis Law Report

JULY 20, 2021

This bill mandated that the Division of Criminal Justice in the Department of Public Safety conduct a study of the impacts of Amendment 64, particularly as these relate to law enforcement activities. This report seeks to establish and present the baseline measures for the metrics specified in S.B. 13-283 (C.R.S.

Data 76

Data Legalization Marijuana Safety 76

Cannabis Law Report

SEPTEMBER 11, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

Canna Law Blog

NOVEMBER 29, 2019

In addition, the FDA reiterates its view that Hemp-CBD cannot be added to food or dietary supplements and states that it “cannot conclude that CBD is generally recognized as safe (GRAS) among qualified experts for its use in human or animal food” based on the available data. Consumer Update. Conclusion.

Hemp 145

Hemp CBD Data Food 145

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Puff Puff Post

FEBRUARY 24, 2020

These results raise safety and efficacy concerns. The findings will be presented at the 20 th International Congress of the International Society for Ethnopharmacology to be held in Thessaloniki, Greece , in April 2020. TEL AVIV, Israel , Feb. billion by 2025 growing at an impressive CAGR of 32.6%.

CBD 96

CBD Safety Pharmaceutical Media 96

Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

MAY 26, 2022

This data helps Californians understand the work we have ahead of us in realizing the promises of cannabis legalization, including supporting access to a safe, legal, and equitable cannabis market across the state and combating the unregulated, illicit market”. The data tool can be found on the DCC website here: [link]. Tweet this.

Data 52

Data Access Business Retail 52

Illinois News Joint

JANUARY 5, 2024

A copy of the transporter’s registration and a manifest for the delivery shall be present in any vehicle transporting cannabis. The GPS tracking system shall also be able to store historic data (for no less than 12months) and shall permit the Department to search all real-time and archived data upon request.

Compliance 104

Compliance Compliance Agriculture Policy 104

Otherside Farms

JANUARY 25, 2019

Lead author Dr. Tim England, honorary consultant stroke physician at the University of Nottingham and Royal Derby Hospital, presented the findings at this week’s annual UK Stroke Forum conference. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial.”.

Clinical Trials 74

Clinical Trials Marijuana Cannabinoids Data 74

Veriheal

NOVEMBER 21, 2023

Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis. The buddie can be paired with a mobile app that tracks consumption, correlating it with health data from devices like WHOOP, Apple Watch, or Fitbit.

Research and Development 110

Research and Development Consumption Education Data 110

Cannabis Law Report

JUNE 15, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 81

Compliance Compliance Seed-To-Sale Data 81

Cannabis Law Report

SEPTEMBER 15, 2021

From December 2020 through July 2021, the FDA received adverse event reports from both consumers and law enforcement describing 22 patients who consumed delta-8 THC products; of these, 14 presented to a hospital or emergency room for treatment following the ingestion. brownies, gummies). exposures to any substance(s).

THC 105

THC Pets Events Hemp 105

The Cannigma

FEBRUARY 2, 2021

“Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

Patients 97

Patients Clinical Trials Research and Development Treatment 97

Cannabis Law Report

JANUARY 23, 2020

The European Food Safety Authority (EFSA) has looked at THC levels in 12 different categories of hemp foods, including hemp oil, breads and teas. The January report from the European Food Safety Authority (EFSA) looked at THC levels in 12 different categories of hemp foods, including hemp oil, breads and teas. Davide Arcella . .

Food 45

Food Safety THC Hemp 45

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.

Business 95

Business Data Wellness and Beauty Safety 95

Greenspoon Marder Cannabis Law Group Blog

JUNE 4, 2019

This was FDA’s first meeting to hear presentations from manufacturers, neurologists, attorneys, parents, innovators and leaders of hemp and CBD voice their concerns on the implementation of the 2018 Farm Bill. Greenspoon Marder Partner Jessica Wasserman was in attendance to assist clients preparing for their presentations.

CBD 74

CBD Research and Development Safety Topical 74

Cannabis Law Report

FEBRUARY 24, 2022

present an imminent health risk. A major observation describes a situation that may result in a risk to public health or public safety, or may involve fraud, or may increase the risk of diversion, prevent the detection of diversion or health risk. A compliant inspection rating may be assigned even when observations are present.

Compliance 52

Compliance Compliance Data Safety 52

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. Chris Ray , PhD : Interventional Pain Physician.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

OCTOBER 15, 2021

At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). Both meetings are being held virtually. President and Chief Executive Officer of Goldfinch Bio. “In

Clinical Trials 40

Clinical Trials Research and Development Data Patients 40

Cannabis Law Report

OCTOBER 9, 2021

Data from the Denver District Attorney’s office shows only 47 cases related to psychedelic mushrooms since May 2019 decriminalization. The report, first reported on by Westword, will be presented to a Denver City Council committee in November. The Denver Post reports.

Decriminalization 52

Decriminalization Law Data Safety 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 121

Research and Development Data THC Clinical Trials 121

CannaMD

APRIL 28, 2021

The authors begin by acknowledging the need to clarify the narrative surrounding marijuana use, which over the course of 50 years has moved from institutional demonization to its present and growing status as a socially accepted therapeutic and recreational substance. Medical Marijuana: Employee Rights & Safety.

Marijuana 138

Marijuana Data Legalization Consumption 138

Cannabis Law Report

JUNE 14, 2021

At present, there are no federally-required testing regulations for hemp and each state has its own set of requirements, making it difficult for consumers to navigate the safety of products and for companies to qualify products beyond individual state standards.

Hemp 80

Hemp Compliance Compliance Safety 80

Veriheal

AUGUST 14, 2023

This directive, coupled with Visa’s similar crackdown on cannabis transactions via cashless ATMS in 2021, presents a significant hurdle for both consumers and cannabis dispensaries. Lastly, the absence of card transactions severely restricts the financial data available to these businesses for analysis and strategic planning.

Banking 98

Banking Dispensary Recreational Cannabis 98

Cannabis Law Report

JULY 28, 2021

Collaborating with County departments, community leaders and other agencies to obtain data, provide analysis and convey results that support the Supervisor’s policy agenda. Recommend and develop more effective strategies to address policy priorities based on research, data and stakeholder buy-in.

Policy 81

Policy Legislation Research and Development Data 81

Veriheal

JANUARY 11, 2023

Not only this, but Gaize recently completed the largest clinical trial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. In what way(s) do you feel that your science-backed real-time cannabis impairment detection device will have an impact on road and workplace safety?

Clinical Trials 98

Clinical Trials THC Data Safety 98

Cannabis Law Report

JUNE 10, 2021

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 45

Policy Safety Marijuana Data 45

Cannabis Law Report

MAY 9, 2022

Preferred candidates will have seven years prior experience in a policy-related management role; experience with professional exposure to the cannabis industry or policy issues related to public health and safety; experience with a strong analytical background and experience working with large data sets.

Policy 52

Policy Research and Development Safety Data 52

SpeedWeed

MARCH 26, 2021

In March, last year the US Food and Drug Administration (FDA) requested specific data on liver toxicity data after saying it believed from CBD use posed ‘real risks’ to human health. Data To Be Used In UK . UK Requires CBD Safety Evidence. It will allow us to differentiate ourselves from the people that don’t.

CBD 52

CBD Business Data Safety 52

The Cannigma

FEBRUARY 25, 2021

Often simply referred to as caryophyllene, this naturally occurring terpene is not just present in cannabis — it is quite common among plants, including many fruits, vegetables, herbs, and spices. It is a common component of many essential oils and is thought to be present in varying amounts in at least half of all flower-producing plants.

Terpenes 122

Terpenes Oil Cannabinoids Conditions 122

Cannabis Law Report

AUGUST 16, 2021

It is also a tool used to “determine the nature and scope of child abuse and neglect” and compare Arizona data to national trends, regardless of whether that neglect or abuse arose from the lawful or unlawful use of substances, a mental illness or incapacity, or simply an inability to properly care for a child. 600 USD raised of $400 goal.

Safety 116

Safety Patients Cannabis Law 116

Veriheal

MAY 16, 2022

Following the successful experiment into the potential safety and efficacy of using ketamine for Parkinson’s patients, the university proceeded to sign an exclusive licensing partnership with Pharmather Inc. , The study’s outcome will be revealed during a medical congress presentation no later than June 2022.

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Veriheal

MAY 17, 2022

Sarah Cuschieri explains that the STROBE guidelines were created as a means of aiding authors to ensure the high-quality presentation of the conducted observational study. The researchers suggest that SHCS “in the home is not safe and that public perceptions of SHCS safety must be addressed.”. Does the Data Justify the Conclusions?

Concentrates 98

Concentrates Data Conditions Cannabis 98

Cannabis Law Report

DECEMBER 2, 2021

IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 40

Clinical Trials Data Patients THC 40